Search results
Results from the WOW.Com Content Network
The Mammography Quality Standards Act (MQSA) was enacted by the United States Congress to regulate the quality of care in mammography. The act was officially effective in 1994, and was extended in 2004 to continue through 2007. The U.S. Food and Drug Administration (FDA) began inspections of mammography facilities to ensure compliance in 1995 ...
In 1982, the organizational units at the FDA that regulated medical devices and radiation-emitting products merged to form the Center for Devices and Radiological Health (CDRH). Former leaders of CDRH [15] Jeffrey Shuren, M.D., J.D., CDRH Director 2009 – 2024; Daniel Schultz M.D., CDRH Director 2004 – 2009
The 118th United States Congress, which began on January 3, 2023, and ended on January 3, 2025, has enacted 274 public laws and zero private laws. [1] [2] [3]In contrast with previous Congresses, which generally enacted their first laws no later than January or February, the 118th Congress's first law was enacted on March 20. [4]
Digital mammography is a specialized form of mammography that uses digital receptors and computers instead of X-ray film to help examine breast tissue for breast cancer. [9] The electrical signals can be read on computer screens, permitting more manipulation of images to allow radiologists to view the results more clearly.
AQSIQ was formed as the successor government body to the State Bureau of Quality and Technological Supervision (SBQTS). [3]: 52 In 2005, AQSIQ established a sui generis system to cover the use of geographical indication products through the 2005 Provisions on the Protection of GI Products.
The regulations set out specific requirements for "nonidentification." Research — This exception allows disclosure to researchers conducting certain types of research projects. If protected health information is involved, the HIPAA privacy and security rules also apply. Food and Drug Administration (FDA) — PSWP may be disclosed to the FDA
A principal author of this law was Royal S. Copeland, a three-term U.S. senator from New York. [3] In 1968, the Electronic Product Radiation Control provisions were added to the FD&C. Also in that year the FDA formed the Drug Efficacy Study Implementation (DESI) to incorporate into FD&C regulations the recommendations from a National Academy of ...
The bill was written in response to the New England Compounding Center meningitis outbreak that took place in 2012, which killed 64 people. [2] The bill was signed by President Obama on November 27, 2013. Title I of the DQSA comprises the Compounding Quality Act (CQA), which amends regulations concerning compounding drugs.